These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9822885)

  • 1. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice.
    Gelot A; Francés B; Gicquel S; Zajac JM
    Eur J Pharmacol; 1998 Oct; 358(3):203-6. PubMed ID: 9822885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
    Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
    Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
    Gelot A; Mazarguil H; Dupuy P; Francés B; Gouardères C; Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Aug; 354(2-3):167-72. PubMed ID: 9754917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide FF, pain and analgesia.
    Roumy M; Zajac JM
    Eur J Pharmacol; 1998 Mar; 345(1):1-11. PubMed ID: 9593588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central effects of neuropeptide FF on intestinal motility in naive and morphine-dependent rats.
    Gelot A; Fioramonti J; Zajac JM; Bueno L
    Neuropeptides; 1995 Nov; 29(5):245-50. PubMed ID: 8587659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
    Dupouy V; Zajac JM
    Eur J Pharmacol; 1997 Jul; 330(2-3):129-37. PubMed ID: 9253945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain.
    Rothman RB; Brady LS; Xu H; Long JB
    Peptides; 1993; 14(6):1271-7. PubMed ID: 8134310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis.
    Dupouy V; Zajac JM
    Regul Pept; 1995 Nov; 59(3):349-56. PubMed ID: 8577940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
    Gouardères C; Sutak M; Zajac JM; Jhamandas K
    Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat.
    Oberling P; Stinus L; Le Moal M; Simonnet G
    Peptides; 1993; 14(5):919-24. PubMed ID: 8284268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing interplay between Neuropeptide FF and nitric oxide in antinociception and hypothermia.
    Zajac JM; Latapie JP; Francés B
    Peptides; 2000 Aug; 21(8):1209-13. PubMed ID: 11035207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of neuropeptide FF-related peptides in rodent spinal cord.
    Bonnard E; Burlet-Schiltz O; Francés B; Mazarguil H; Monsarrat B; Zajac JM; Roussin A
    Peptides; 2001 Jul; 22(7):1085-92. PubMed ID: 11445238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects.
    Wang Z; Xu B; Jiang C; Zhang T; Zhang M; Li N; Zhang Q; Xu K; Chen D; Xiao J; Fang Q
    J Pain; 2020; 21(3-4):477-493. PubMed ID: 31521796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice.
    Kavaliers M
    Neurosci Lett; 1990 Jul; 115(2-3):307-12. PubMed ID: 2234508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.
    Quelven I; Roussin A; Burlet-Schiltz O; Gouardères C; Tafani JA; Mazarguil H; Zajac JM
    Eur J Pharmacol; 2002 Aug; 449(1-2):91-8. PubMed ID: 12163111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
    Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
    Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.
    Sánchez-Blázquez P; García-Espãna A; Garzón J
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1423-31. PubMed ID: 9067332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.